BRYCE YATES: Open Payments
NPI 1487184446 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 89 payments from 12 companies in 2025. Trend: 2023 $1,263 · 2024 $1,241 · 2025 $1,501
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 27 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $239 |
| Alkermes, Inc. | 10 | $191 |
| Teva Pharmaceuticals USA, Inc. | 9 | $167 |
| Lundbeck LLC | 11 | $157 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| Janssen Pharmaceuticals, Inc | 6 | $101 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $32 |
Products named: REXULTI, CAPLYTA, ARISTADA, ABILIFY MAINTENA, INGREZZA, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
